Cullen/Frost Bankers’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.71M Buy
59,801
+4,118
+7% +$395K 0.06% 214
2026
Q1
$5.77M Buy
55,683
+7,086
+15% +$803K 0.07% 203
2025
Q4
$4.9M Sell
48,597
-5,929
-11% -$644K 0.05% 220
2025
Q3
$6.72M Buy
54,526
+693
+1% +$86K 0.08% 189
2025
Q2
$6.46M Buy
53,833
+8,437
+19% +$1.13M 0.08% 187
2025
Q1
$6.68M Buy
45,396
+1,519
+3% +$232K 0.09% 185
2024
Q4
$7.13M Buy
43,877
+1,811
+4% +$296K 0.1% 177
2024
Q3
$6.85M Buy
42,066
+1,554
+4% +$230K 0.09% 180
2024
Q2
$5.53M Buy
40,512
+38,369
+1,790% +$5.33M 0.08% 191
2024
Q1
$328K Sell
2,143
-134
-6% -$20K ﹤0.01% 417
2023
Q4
$325K Sell
2,277
-1,700
-43% -$227K 0.01% 423
2023
Q3
$521K Buy
3,977
+134
+3% +$20.4K 0.01% 370
2023
Q2
$611K Sell
3,843
-255
-6% -$41.1K 0.01% 357
2023
Q1
$648K Buy
4,098
+194
+5% +$29.1K 0.01% 344
2022
Q4
$548K Sell
3,904
-237
-6% -$33.6K 0.01% 377
2022
Q3
$532K Sell
4,141
-42
-1% -$6.06K 0.01% 364
2022
Q2
$590K Sell
4,183
-1,100
-21% -$157K 0.01% 353
2022
Q1
$734K Sell
5,283
-820
-13% -$126K 0.01% 342
2021
Q4
$1.06M Sell
6,103
-1,188
-16% -$198K 0.02% 297
2021
Q3
$1.21M Sell
7,291
-2,196
-23% -$378K 0.02% 277
2021
Q2
$1.71M Sell
9,487
-5,070
-35% -$925K 0.03% 262
2021
Q1
$2.81M Sell
14,557
-911
-6% -$175K 0.06% 223
2020
Q4
$3.12M Sell
15,468
-2,255
-13% -$467K 0.07% 197
2020
Q3
$3.73M Sell
17,723
-2,769
-14% -$617K 0.09% 181
2020
Q2
$4.5M Sell
20,492
-260
-1% -$51.9K 0.12% 168
2020
Q1
$3.6M Sell
20,752
-959
-4% -$158K 0.12% 154
2019
Q4
$3.33M Sell
21,711
-457
-2% -$68.3K 0.09% 182
2019
Q3
$3.37M Sell
22,168
-1,428
-6% -$226K 0.1% 178
2019
Q2
$3.61M Sell
23,596
-4,065
-15% -$621K 0.11% 165
2019
Q1
$4.44M Buy
27,661
+52
+0.2% +$8.07K 0.14% 150
2018
Q4
$4.26M Buy
27,609
+3,928
+17% +$612K 0.16% 147
2018
Q3
$3.56M Sell
23,681
-12,718
-35% -$1.81M 0.11% 166
2018
Q2
$4.92M Sell
36,399
-4,198
-10% -$518K 0.15% 146
2018
Q1
$5.4M Sell
40,597
-588
-1% -$79K 0.16% 145
2017
Q4
$6.13M Sell
41,185
-8,651
-17% -$1.18M 0.19% 138
2017
Q3
$6.57M Sell
49,836
-1,874
-4% -$252K 0.22% 130
2017
Q2
$6.89M Sell
51,710
-91
-0.2% -$12.3K 0.23% 126
2017
Q1
$6.98M Buy
51,801
+957
+2% +$124K 0.24% 121
2016
Q4
$6.1M Buy
50,844
+2,344
+5% +$276K 0.21% 126
2016
Q3
$6.07M Sell
48,500
-1,104
-2% -$145K 0.22% 123
2016
Q2
$6.87M Buy
49,604
+923
+2% +$120K 0.25% 114
2016
Q1
$6.14M Sell
48,681
-770
-2% -$97.9K 0.23% 116
2015
Q4
$6.27M Sell
49,451
-1,760
-3% -$218K 0.24% 118
2015
Q3
$5.92M Buy
51,211
+34,925
+214% +$3.92M 0.23% 117
2015
Q2
$1.69M Buy
16,286
+1,150
+8% +$124K 0.06% 207
2015
Q1
$1.67M Buy
15,136
+2,520
+20% +$274K 0.06% 207
2014
Q4
$1.31M Hold
12,616
0.05% 229
2014
Q3
$1.21M Buy
12,616
+572
+5% +$51.7K 0.05% 235
2014
Q2
$1.1M Buy
12,044
+1,700
+16% +$152K 0.04% 241
2014
Q1
$911K Buy
10,344
+1,258
+14% +$110K 0.04% 248
2013
Q4
$843K Buy
9,086
+900
+11% +$81.1K 0.04% 249
2013
Q3
$669K Hold
8,186
0.03% 256
2013
Q2
$680K Buy
+8,186
New +$704K 0.04% 252

Other funds holding CLX

Cullen/Frost Bankers's CLX Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Clorox (CLX) stake by 7.4% in Q2 2026, buying an estimated $395K and bringing the position to 59,801 shares worth $5.71M. The position accounts for 0.06% of the portfolio, ranked #214.

Cullen/Frost Bankers first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.13M in Q4 2024. 598 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Cullen/Frost Bankers held 59,801 shares of Clorox worth $5.71M as of Q2 2026.
  • Cullen/Frost Bankers bought 4,118 Clorox shares in Q2 2026, an estimated $395K.
  • Clorox made up 0.06% of Cullen/Frost Bankers's portfolio in Q2 2026, its #214 holding.
  • Cullen/Frost Bankers first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
  • Cullen/Frost Bankers's Clorox position peaked at $7.13M in Q4 2024.
  • 598 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.